Anti-MMP2 antibody [4D3] (ab2462)

ab2462 has been referenced in 10 publications.

• Cui L  et al. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide. Mol Med Rep 13:2032-8 (2016). WB ; Human . PubMed: 26781180
• Lu X  et al. Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction. Onco Targets Ther 9:4343-9 (2016). IHC . PubMed: 27486337
• Qi JS  et al. Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer. Oncol Lett 9:1297-1302 (2015). IHC ; Rabbit . PubMed: 25663901
• Ponceau A  et al. aII-spectrin regulates invadosome stability and extracellular matrix degradation. PLoS One 10:e0120781 (2015). PubMed: 25830635
• Silva EJ  et al. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells. Int J Biochem Cell Biol 55:279-87 (2014). WB ; Human . PubMed: 25236491
• Singh M  et al. Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Gynecol Oncol 122:178-82 (2011). IHC . PubMed: 21514631
• Kean MJ  et al. VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. J Cell Sci 122:4089-98 (2009). ICC/IF ; Human . PubMed: 19910495
• Wang J  et al. Differential gene expression in normal esophagus and Barrett's esophagus. J Gastroenterol 44:897-911 (2009). IHC-P ; Human . PubMed: 19468668
• Murray GI  et al. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43:791-7 (1998). PubMed: 9824606
• Murray GI  et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185:256-61 (1998). PubMed: 9771478